09:01 AM EDT, 10/13/2025 (MT Newswires) -- Health care stocks were steady to higher premarket Monday, with the Health Care Select Sector SPDR Fund (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) up 0.6%.

Arcus Biosciences ( RCUS ) stock was up more than 8% after the company said a phase 2 study on various combinations of domvanalimab plus zimberelimab with chemotherapy achieved a 26.7-month median overall survival in patients with advanced stomach and esophageal cancer, including tumors not removable by surgery, with a 50% two-year survival rate.